Form 6K Innate Pharma For: 19 March
#Innate Pharma #Form 6-K #SEC #filing #March 19 #regulatory #corporate update
📌 Key Takeaways
- Innate Pharma filed a Form 6-K with the SEC on March 19.
- The filing is a standard report for foreign private issuers.
- It may contain financial results, corporate updates, or material events.
- Specific content details are not provided in the given text.
🏷️ Themes
Regulatory Filing, Biopharmaceuticals
Entity Intersection Graph
No entity connections available yet for this article.